» Articles » PMID: 1385474

Interleukin 4 Inhibits in Vitro Proliferation of Leukemic and Normal Human B Cell Precursors

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1992 Nov 1
PMID 1385474
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, we have investigated the effects of IL-4 on the proliferation and differentiation of leukemic and normal human B cell precursors (BCP). We have demonstrated that IL-4 significantly inhibited spontaneous [3H]thymidine ([3H]-TdR) incorporation by leukemic blasts from some B lineage acute lymphoblastic leukemia (BCP-ALL) patients (8 of 14). Furthermore, IL-4 was found to suppress the spontaneous and factor-dependent (IL-7 and IL-3) proliferation of normal BCP (CD10+ surface [s] IgM- cells) isolated from fetal bone marrow. Maximum growth inhibition of either leukemic or normal BCP was reached at low IL-4 concentrations (10 U/ml), and the effect was specifically neutralized by anti-IL-4 antibody. IL-4 was further found to induce the expression of CD20 antigen on BCP-ALL cells from a number of the cases examined (5 of 8), but in contrast to leukemic cells, IL-4 failed to induce CD20 antigen on normal BCP. Finally, IL-4 was found to induce neither the expression of cytoplasmic mu chain, nor the appearance of sIgM+ cells in cultures of normal or leukemic BCP. Our data indicate that IL-4 has the potential to inhibit cell proliferation in leukemic and normal human B lymphopoiesis but is unable to drive the transition from BCP to mature B cells.

Citing Articles

Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.

Smith N, Tierney R, Wei W, Vockerodt M, Murray P, Woodman C PLoS One. 2013; 8(5):e64868.

PMID: 23724103 PMC: 3664578. DOI: 10.1371/journal.pone.0064868.


IL-7 sensitizes human pre-B cells but not pro-B cells to Fas/APO-1 (CD95)-mediated apoptosis.

Levy Y, Benlagha K, Buzyn A, Colombel M, Brouet J, Lassoued K Clin Exp Immunol. 1997; 110(2):329-35.

PMID: 9367421 PMC: 2265507. DOI: 10.1111/j.1365-2249.1997.tb08336.x.


Human B cell precursors proliferate and express CD23 after CD40 ligation.

Saeland S, Duvert V, Moreau I, Banchereau J J Exp Med. 1993; 178(1):113-20.

PMID: 7686210 PMC: 2191089. DOI: 10.1084/jem.178.1.113.

References
1.
Okabe M, Sugiwura T, Tanaka M, Miyagishima T, Saiki I, Minagawa T . Inhibitory effect of interleukin-4 on the in vitro growth of Ph1-positive acute lymphoblastic leukemia cells. Blood. 1991; 78(6):1574-80. View

2.
Rousset F, Garcia E, Banchereau J . Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med. 1991; 173(3):705-10. PMC: 2118825. DOI: 10.1084/jem.173.3.705. View

3.
Findley Jr H, Zhou M, Davis R, Hnath R, Ragab A . Effects of low molecular weight B-cell growth factor on proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia. Blood. 1990; 75(4):951-7. View

4.
Hunt P, Robertson D, Weiss D, Rennick D, Lee F, Witte O . A single bone marrow-derived stromal cell type supports the in vitro growth of early lymphoid and myeloid cells. Cell. 1987; 48(6):997-1007. DOI: 10.1016/0092-8674(87)90708-2. View

5.
Wormann B, Anderson J, Liberty J, GAJL-PECZALSKA K, BRUNNING R, Silberman T . Establishment of a leukemic cell model for studying human pre-B to B cell differentiation. J Immunol. 1989; 142(1):110-7. View